Regulatory Approval

Holtec and EDF unveil a plan to build four SMR-300 nuclear reactors at a former UK coal plant, a key step in Britain's energy security strategy.

Telcoin just launched the first regulated, on-chain bank accounts in the US. What does it mean when your dollars live on a blockchain? A look at the breakthrough.

Pathway Labs' FDA-cleared AI, EchoNext, detects hidden heart disease. A key partnership and $8.5M seed round signal a major shift for MedTech investors.

With 40M more patients now covered, Kerecis's fish-skin technology is set for accelerated adoption, driven by powerful clinical data and payor confidence.

A new railway in Laredo, Texas, aims to supercharge the US-Mexico trade corridor, promising to reverse a logistics decline and create a new model for industrial growth.

New Relic is pursuing top-tier FedRAMP High and DoD IL4 security authorizations, a strategic move to unlock the government's most sensitive cloud contracts.

Quoin Pharma's new drug name is a key step, but the path to the first-ever treatment for a rare skin disease reveals the complex interplay of innovation and finance.

An AI firm known for shopper analytics is rapidly expanding its financial services to 3 million unbanked Americans. Is this the future of financial inclusion?

An EY award for Rhythm Express founders highlights a deeper story of strategic innovation, patient-centric design, and the future of remote health monitoring.

BioMendics secured a key FDA Fast Track designation for its EBS therapy, a strategic move that de-risks development and signals a new era for rare disease treatment.

A new, fast-acting neurotoxin with a two-week lifespan just hit the market. Allergan's Boey® aims to capture hesitant consumers with a low-commitment 'trial run'.

A pivotal NCCN guideline update for bladder cancer validates Natera's Signatera test, ushering in a new era of personalized, MRD-guided cancer treatment.

Stunningly high-grade copper and gold intercepts at the Lunahuasi project suggest a discovery of global scale, positioning NGEx Minerals at the heart of a new resource boom.

Spotlight Medical's myStage Dx secures tough IVDR CE mark, using AI on standard lab slides to help doctors pinpoint which patients can safely avoid chemo.

The European Commission has approved MAVIRET for acute Hepatitis C, a move set to streamline patient care and accelerate progress against a silent epidemic.

AbbVie's blockbuster SKYRIZI wins European approval for pediatric psoriasis, unlocking a new market and offering a new standard of care to young patients.

Elevar Therapeutics' new trial for lirafugratinib aims for a tumor-agnostic label, a strategic move to redefine cancer treatment beyond a single indication.

With a key regulatory win, the American Water-Essential Utilities merger moves closer to creating a utility behemoth. What does this mean for customers?

PorTal Access wins FDA clearance for FLEXI-PORT™, a device poised to disrupt a stagnant market by focusing on patient comfort and clinical versatility.

Lincoln Gold's Bell Mountain project is nearing construction, set to trigger a lucrative 3% royalty for Globex in a gold market far hotter than projections.